Related Experiment Video
Updated: Aug 23, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
A predictive study of congenital heart disease and need for care
Insights
Estimating congenital heart disease prevalence in California children is crucial for healthcare planning. This study modeled prevalence to inform resource allocation and improve care for affected youth.
Area of Science:
- Pediatric Cardiology
- Public Health
- Health Services Research
Background:
- Accurate prevalence data for congenital heart disease (CHD) are vital for effective long-term healthcare planning, including resource allocation and workforce development.
- Understanding the natural history of CHD and utilizing population estimates are key components in developing predictive models for disease prevalence.
- Previous estimations of CHD prevalence have been limited, necessitating updated and localized data for targeted interventions.
Purpose of the Study:
- To develop and apply a model for estimating the prevalence of congenital heart disease in children and adolescents in California.
- To provide essential data for healthcare providers and policymakers to facilitate long-term planning and resource management for pediatric cardiovascular care.
- To establish a methodology that can be adapted for national-level CHD prevalence estimation and healthcare planning.
Main Methods:
- A model was constructed using incidence figures, knowledge of the natural history of congenital heart disease, and predicted population estimates for California.
- Data were gathered and analyzed to reflect the prevalence of various types of congenital heart defects within the specified age group.
- The model specifically estimated the number of children under 21 years of age with CHD in California as of 1975.
Main Results:
- An estimated 17,531 children under 21 years of age in California had congenital heart disease in 1975.
- Ventricular septal defects were the most common, accounting for 24% of cases, followed by pulmonary stenosis (23%), atrial septal defects (11%), and aortic stenosis (9%).
- Other forms of congenital heart disease comprised the remaining 33% of the estimated prevalence.
Conclusions:
- The developed model provides a robust estimation of congenital heart disease prevalence in a large pediatric population.
- These prevalence estimates are critical for planning the necessary medical resources to ensure optimal care for children with CHD.
- The methodology employed in this California-based study offers a valuable framework for similar prevalence estimations and healthcare planning nationwide.
Abstract:
For long-term planning in the delivery of health care, prevalence data are essential for budget estimates in terms both of distribution and training of manpower and fiscal responsibility. From incidence figures, from the knowledge of the natural history of congenital heart disease and from predicted population estimates it is possible to construct a model that reflects the prevalence of congenital heart disease. This has been done for the state of California; the methods used and the data gathered should prove useful nationally. It is estimated that there were in 1975 in California 17,531 children under 21 years of age with congenital heart disease; 24 percent of these had ventricular septal defects and 23 percent had pulmonary stenosis, 11 percent had atrial septal defects and 9 percent had aortic stenosis; the other forms of congenital heart disease constituted the remaining 33 percent. Based on these estimates it is then possible to plan the medical resources necessary for optimal care.
Related Concept Videos
Imaging Studies for Cardiovascular System III: X-Ray
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
Acute Coronary Syndrome III: Diagnostic Studies
Heart Failure IV: Classification and Diagnostic Evaluation
Cardiomyopathy III: Hypertrophic Cardiomyopathy

